Emodin enhances cisplatin sensitivity in non-small cell lung cancer through Pgp downregulation

Cisplatin resistance is one of the main causes of chemotherapy failure and tumor progression in non-small cell lung cancer (NSCLC). Emodin has been demonstrated to induce NSCLC cell apoptosis and act as a potential cancer therapeutic agent. However, whether emodin could affect NSCLC cell sensitivity...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Shuai, Wang, Jincheng, Lu, Chang, Xu, Zelin, Chai, Jing-Jing, Ke, Qing, Deng, Xin-Zhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856686/
https://www.ncbi.nlm.nih.gov/pubmed/33613719
http://dx.doi.org/10.3892/ol.2021.12491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856686/
https://www.ncbi.nlm.nih.gov/pubmed/33613719
http://dx.doi.org/10.3892/ol.2021.12491

Ejemplares similares